Real-World Study of Cligabalin for the Treatment of Neurogenic Rosacea
NCT07606820 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2026-05-26
Summary
A Real-World Study of Cligabalin(HSK16149) for the Treatment of Neurogenic Rosacea
Conditions
- Rosacea
Interventions
- DRUG
-
HSK16149 20mg BID
different dose
- DRUG
-
HSK16149 20mg qd
different dose
Sponsors & Collaborators
-
The First Affiliated Hospital with Nanjing Medical University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-20
- Primary Completion
- 2026-10-30
- Completion
- 2026-12-30
Countries
- China
Study Locations
More Related Trials
-
Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea
NCT01579084 ·Status: COMPLETED ·Phase: PHASE1
-
AGN-199201 for the Treatment of Erythema With Rosacea
NCT01735201 ·Status: COMPLETED ·Phase: PHASE2
-
Dermocosmetic Treatment for Facial Redness in Rosacea With or Without Laser Therapy
NCT07521462 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Topical Agent for Treatment of Red Skin
NCT00279890 ·Status: COMPLETED ·Phase: PHASE1
-
Analysis of Factors Associated With the Efficacy of 595-nm Pulsed Dye Laser Treatment for Rosacea
NCT07410533 ·Status: COMPLETED ·Phase: NA
-
The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin
NCT06516939 ·Status: RECRUITING ·Phase: NA
-
FMRF Combined With 30% SSA in the Treatment of Rosacea
NCT06969300 ·Status: COMPLETED ·Phase: NA
-
Potassium Titanyl Phosphate Laser Versus Pulsed Dye Laser for Rosacea - a Prospective Study
NCT05771298 ·Status: UNKNOWN ·Phase: NA
-
Combination Gel and Vascular ND in Mild to Moderate Rosacea
NCT01631656 ·Status: COMPLETED ·Phase: NA
-
Photodynamic Therapy for Papulopustular Rosacea
NCT02075671 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Study Testing the Effects of Chemical Peels in Patients With Rosacea
NCT04889703 ·Status: WITHDRAWN ·Phase: NA
-
Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness
NCT01529996 ·Status: COMPLETED ·Phase: NA
-
Evaluating Use of Topical Imipramine and Amitriptyline in Reducing Ultraviolet B Light-Induced Redness in Patients With Rosacea
NCT06312813 ·Status: RECRUITING ·Phase: PHASE2
-
Assessing the Quality of Life of Patients With Rosacea
NCT06271135 ·Status: COMPLETED ·Phase: NA
-
Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions
NCT01735942 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Comparison of Nicotinamide Treatments for Actinic Keratosis
NCT07049068 ·Status: COMPLETED ·Phase: PHASE1
-
ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis
NCT02126670 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Single Microneedle Radiofrequency for Moderate-to-Severe Acne Vulgaris
NCT04213638 ·Status: UNKNOWN ·Phase: NA
-
Pulsed Dye Laser and Intense Pulsed Light Configured With Different Wavelength Bands in Improving Erythematotelangiectatic Rosacea
NCT05360251 ·Status: UNKNOWN ·Phase: NA
-
Topical Rapamycin for Fibrofolliculomas
NCT00928798 ·Status: COMPLETED ·Phase: PHASE3
-
Long Pulse 1064 nm Nd:YAG Laser in the Treatment of Erythematotelangiectatic Rosacea and Other Erythematous Telangiectatic Facial Conditions
NCT06908915 ·Status: COMPLETED ·Phase: NA
-
Low Fluence 1064nm Laser Hair Reduction for Pseudofolliculitis Barbae in Skin Types IV, V, VI
NCT00402129 ·Status: COMPLETED ·Phase: NA
-
Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea
NCT06033352 ·Status: COMPLETED ·Phase: PHASE2
-
Patient and Clinician Reported Outcomes for Tirbanibulin Effectiveness and Safety in Actinic Keratosis
NCT05260073 ·Status: COMPLETED
-
Evaluate RLS-1496 Topical Cream for Actinic Keratosis
NCT07340697 ·Status: RECRUITING ·Phase: PHASE1/PHASE2